Live feed
Filing
SC 13G
SC 13G0000935836-21-000002·LYTTON LAURENCE W
Schedule 13G ownership disclosure
SUNESIS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 867328874
Event date: 2020-12-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,598,519
- Percent of class
- 8.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-21-000002
- Form type
- SC 13G
- Filer
- LYTTON LAURENCE W
- CIK
- CIK 1105806
- Filed
- Jan 04, 2021
- Reporting period
- Dec 22, 2020
- Description
- Schedule 13G beneficial ownership